This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jennings, C.
Right arrow Articles by Bremer, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jennings, C.
Right arrow Articles by Bremer, J. W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2002, p. 1067-1068, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1067-1068.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Ratio of Two Successive Optical Densities from the Roche HIV-1 Monitor Test as a Measure of Accuracy of Estimates of Human Immunodeficiency Virus RNA Concentration

Cheryl Jennings,1* Donald J. Brambilla,2 and James W. Bremer1

Rush Medical College, Chicago, Illinois 60612,1 New England Research Institutes, Inc., Watertown, Massachusetts 024722

Received 22 May 2001/ Returned for modification 17 October 2001/ Accepted 6 December 2001

In the Roche Amplicor HIV-1 Monitor Test, the ratio of the optical density used to estimate the RNA concentration and the optical density of the preceding or the following dilution can be used to identify specimens with inaccurate results which should be retested. We present an algorithm for the identification of such results.

* Corresponding author. Mailing address: Rush Medical College, Department of Immunology/Microbiology, 1653 W. Congress Parkway, Chicago, IL 60612. Phone: (312) 942-5954. Fax: (312) 942-6787. E-mail: cjenning{at}rush.edu.

Journal of Clinical Microbiology, March 2002, p. 1067-1068, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1067-1068.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Beer, B. E., Doncel, G. F., Krebs, F. C., Shattock, R. J., Fletcher, P. S., Buckheit, R. W. Jr., Watson, K., Dezzutti, C. S., Cummins, J. E., Bromley, E., Richardson-Harman, N., Pallansch, L. A., Lackman-Smith, C., Osterling, C., Mankowski, M., Miller, S. R., Catalone, B. J., Welsh, P. A., Howett, M. K., Wigdahl, B., Turpin, J. A., Reichelderfer, P. (2006). In Vitro Preclinical Testing of Nonoxynol-9 as Potential Anti-Human Immunodeficiency Virus Microbicide: a Retrospective Analysis of Results from Five Laboratories. Antimicrob. Agents Chemother. 50: 713-723 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»